31
Participants
Start Date
January 31, 2005
Primary Completion Date
June 30, 2006
Study Completion Date
July 31, 2006
recombinant human growth hormone
0.005 mg/kg/day for 30 days then increasing, with the Investigator's approval, to 0.010 mg/kg/day from Day 31 to Week 24.
recombinant human growth hormone
0.010 mg/kg/day for 14 days with the opportunity to dose escalate, with the Investigator's approval, on Day 15 to 0.02 mg/kg/day and Day 29 to 0.03 mg/kg/day.
Columbia University, New York
Women's and Children's Hospital of Buffalo, Buffalo
Children's Hospital of Pittsburgh, Pittsburgh
Pediatric Endocrine Associates, Atlanta
Nemours Children's Clinic, Jacksonville
Pediatric Endocrinology Children's Clinic, Tallahassee
Nemours Children's Clinic, Orlando
Children's Hospital of Wisconsin, Milwaukee
Children's Hospital of Orange County, Orange
Lead Sponsor
EMD Serono
INDUSTRY